Dana Farber Cancer Center, Harvard University — Boston, Massachusetts

Dana Farber Cancer Center, Harvard University is a clinical research site located in Boston, Massachusetts, United States 02215.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Dana Farber Cancer Center, Harvard University has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Pancreas Cancer, Peutz-Jeghers Syndrome (PJS), Gene Mutation.

Sponsors: Johns Hopkins University.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana Farber Cancer Center, Harvard University?

Dana Farber Cancer Center, Harvard University has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana Farber Cancer Center, Harvard University conducted?

Dana Farber Cancer Center, Harvard University has 1 clinical trials on record, with 1 currently active. Their work covers Pancreas Cancer, Peutz-Jeghers Syndrome (PJS), Gene Mutation.

Is Dana Farber Cancer Center, Harvard University accredited by Crixeo Health?

Dana Farber Cancer Center, Harvard University has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dana Farber Cancer Center, Harvard University?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.